Xcell Biosciences
Pre-clinicalThe AVATAR™ platform brings physiologically relevant tumor microenvironment (TME) control into cell therapy workflows, improving potency, persistence, and predictability for solid tumor therapies.
Founded
2012
Focus
Cell TherapyOncology
About
The AVATAR™ platform brings physiologically relevant tumor microenvironment (TME) control into cell therapy workflows, improving potency, persistence, and predictability for solid tumor therapies.
Company Info
TypePrivate
Founded2012
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile